您当前的位置:
首页 >
文章列表页 >
The "cytokine storm" in infection and sepsis:win the battle but lose the war
REVIEW | 更新时间:2026-06-10
    • The "cytokine storm" in infection and sepsis:win the battle but lose the war

    • The "cytokine storm" in infection and sepsis:win the battle but lose the war

    • “On June 10, 2026, a team of experts led by Jiang-Bo Fan, Jian-Xin Jiang, Ling Zeng from the School of Department of Trauma Medical CenterandZhen Wang from the School of Department of Critical Care Medicinepublished an article in the MMR, explores cytokine storm mechanisms in severe infections and potential therapies including cytokine antagonists and JAK inhibitors, providing solutions to reduce multiorgan failure mortality.”
    • Jiang-Bo Fan ,Qin-Yuan Li ,Xi-Feng Feng ,Si-Yuan Huang ,Rui Wang ,Feng-Ying Liao ,Di Liu ,Wen-Yi Liu ,Jian-Hui Sun ,Hua-Cai Zhang ,Hui-Ting Zhou ,Jian-Xin Jiang ,Zhen Wang ,Ling Zeng
    • Military Medical Research 2026年13卷第5期 页码:811-832
    • DOI: 10.1186/s40779-025-00678-0     

      中图分类号:
    • 录用:2025-11-24 ,

    移动端阅览

  •  
  •  
  • AI导读

  • HTML全文

  • 图( 3 ) 表( 0 )

  • 参考文献

  • 出版信息

  • 数据统计

78

浏览量

58

下载量

0

CSCD

文章被引用时,请邮件提醒。
提交
工具集
  • BibTeX下载
  • Endnote下载
  • RefMan 下载
  • NoteExpress下载
  • NoteFirst下载

相关文章

Better therapy for combat injury
Metabolic syndrome and risk of sepsis and sepsis-related mortality: evidence from two large prospective cohort studies
Endothelial barrier and sepsis: mechanisms and potential therapeutic strategies
A call for further evidence regarding the association between metabolic syndrome, sepsis, and sepsis-related death
From RCT to mechanistic study: ATRA reverses myofibroblast activation by reprogramming glucose metabolism via HIC1 and PCK1/2 to attenuate hypertrophic scar formation

相关作者

Yong-Ming Yao
Hui Zhang
Shao-Yu Liu
Shao-Kang Xu
Jing-Li Gao
Xiao-Ke Kong
Jian Shi
Ya Miao

相关机构

Trauma Research Center, Fourth Medical Center of the Chinese PLA General Hospital, Fucheng Road 51, Haidian District
Department of Critical Care Medicine and Hematology, the Second Xiangya Hospital, Central South University
Department of Critical Care Medicine and Hematology, the Third Xiangya Hospital, Central South University
Department of Intensive Medicine, Kailuan General Hospital
National Clinical Research Center for Endocrine and Metabolic Diseases, Metabolic Syndrome Research Center, Key Laboratory of Diabetes Immunology, Ministry of Education, and Department of Metabolism and Endocrinology, the Second Xiangya Hospital of Central South University